A comparative longitudinal study between sublingual Misoprostol 600 µg  and conventionally used Oxytocin 20 IU infusion in active management of  third stage of labour from North India

Dr Mushir Shaikh Dr Preeti Kamble, Dr. Balaji Panditrao Nalwad, Dr Sadhna Singhal and Dr Anant Takalkar

A comparative longitudinal study between sublingual Misoprostol 600 µg and conventionally used Oxytocin 20 IU infusion in active management of third stage of labour from North India

Authors

Dr Mushir Shaikh Dr Preeti Kamble, Dr. Balaji Panditrao Nalwad, Dr Sadhna Singhal and Dr Anant Takalkar

Keywords:

blood loss, haemoglobin, sublingual Misoprostol, Oxytocin, active management of third stage of labour.

Abstract

Background: PPH is the most important cause of maternal mortality and morbidity worldwidewith an estimated maternal death of 1,40,000 per year or 1 maternal death every 4 mins. Atleast one quarter (25%) of these deaths is due to PPH. The majority of deaths occur within 4 hours of delivery which indicates

References

Mani M, Sahay PB. Role of Misoprostol 600 µg in active management of third stage of labour: a comparative study with oxytocin 10 U IM. J obstetGynecol India. 2013; 63(5):325-327.

Lalonde A, Okong P, Zulfigar S, Adrien L, Stones W, Fuchtner C, et al. Federation of Gynaecology and obstetrics guidelines (FIGO): Prevention and treatment of postpartum haemorrhage in low-resource settings. Int J Gynaecol Obstet. 2012;117(2):108-118

Downloads

Published

2025-10-17

How to Cite

Dr Mushir Shaikh Dr Preeti Kamble, Dr. Balaji Panditrao Nalwad, Dr Sadhna Singhal and Dr Anant Takalkar. (2025). A comparative longitudinal study between sublingual Misoprostol 600 µg and conventionally used Oxytocin 20 IU infusion in active management of third stage of labour from North India. International Journal of Pharmacy Research & Technology (IJPRT), 15(2), 2538–2546. Retrieved from https://www.ijprt.org/index.php/pub/article/view/1085